Pelvic Floor Telerehabilitation Program
OtherSee experimental and active comparator arms.
NCT Number: NCT05114395
Urinary incontinence (UI) is defined as any involuntary loss of urine. It affects a significant percentage of the population, mainly female, with a prevalence of 21.4% in Portuguese women, having a negative impact on quality of life and sexual function.
About half presents with stress UI (SUI), followed by mixed UI (MUI), with isolated urgency UI being less common.
Pelvic floor rehabilitiation is a first line treatment for SUI and MUI, however, it is not yet defined which is the best treatment program or the ideal strategies to improve adherence to it.
Telerehabilitation assumed a leading role in the covid pandemic phase, although there are few studies on pelvic floor rehabilitation for UI, none in Portugal to date.
The authors aim to evaluate the effectiveness of a hybrid program of pelvic floor rehabilitation in female patients with SUI and MUI with a predominance of SUI, including consultation and face-to-face sessions complemented with telerehabilitation.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Physical and Rehabilitation Medicine Department - Centro Hospitalar Universitário de São João, Porto, Portugal
Randomized longitudinal study including consecutively admitted patients on pelvic floor rehabilitation consultation of the Physical Medicine and Rehabilitation Department of Centro Hospitalar São João for conservative treatment of UI.
Patients who meet the inclusion criteria and do not meet any of the exclusion criteria will be randomized one to one between the intervention group and the control group.
The intervention group includes a hybrid program of face-to-face sessions followed by sessions of video, while the control group develops the entire program in face-to-face sessions.
The effectiveness of the program will be assessed by the results in the UI-related quality of life (primary outcome); UI severity, patient's overall perception of improvement, sexual function, depression/anxiety symptoms and satisfaction and adherence to treatment (secondary outcomes).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
See experimental and active comparator arms.
See experimental and active comparator arms.
Time frame: From admission to discharge of the program, up to 13 weeks.
The primary outcome is the assessment of urinary incontinence related quality of life using the Portuguese Version of KHQ.
Time frame: From admission to discharge of the program, up to 13 weeks.
Assessment of UI severity using the International Continence Society (ICS) pad test.
Time frame: From admission to discharge of the program, up to 13 weeks.
Evaluation of the global perception of improvement of the patient using the Portuguese version of the Patient Global Impression of Improvement (PGI-I) Scale.
The minimum value is 0 and the maximum is 10. A higher score means a better outcome.
Time frame: From admission to discharge of the program, up to 13 weeks.
Evaluation of sexual function using the Portuguese version of the Female Sexual Functioning Index (FSFI)
Time frame: From admission to discharge of the program, up to 13 weeks.
Assessment of the presence of symptoms of depression/anxiety using the Portuguese version of the Hospital Anxiety & Depression Scale (HADS) questionnaire.
The minimum value is 0 and the maximum is 21. A total subscale score of >8 points out of a possible 21 denotes considerable symptoms of anxiety or depression.
Time frame: From admission to discharge of the program, up to 13 weeks.
Assessment of satisfaction with the treatment using the 9-point Likert scale. The minimum value is 1 and the maximum is 9. A higher score means a better outcome.
Time frame: From admission to discharge of the program, up to 13 weeks.
Assessment of adherence to the treatment including compliance to the exercise program (number of performed sessions) and to the behavioral measures.
Time frame: From admission to discharge of the program, up to 16 weeks.
Assessment of UI severity using the Portuguese version of the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF).
Centro Hospitalar De São João, E.P.E.
Other
Comparison Between a Telerehabilitation Program for Urinary Incontinence Versus a Conventional Face-to-face Program: a Longitudinal Study in Pandemic Times
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03443687
Asthenia, Female Urogenital Diseases
Albuquerque, New Mexico, United States
View Trial DetailsNCT07668128
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Taipei City, Banqiao Dist, Taiwan
View Trial DetailsNCT03681678
Burning Vagina, Dyspareunia
Royal Oak, Michigan, United States
View Trial DetailsNCT02906683
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Osaka, Japan
View Trial Details